Mannkind reported $9.89M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adamas Pharmaceuticals ADMS:US 576K 49K
Adma Biologics ADMA:US $ 20.3M 1.46M
Biocryst Pharmaceuticals BCRX:US $ 0.62M 0.27M
Biodelivery Sciences International BDSI:US $ 6.36M 2.08M
Dynavax Technologies DVAX:US $ 60.09M 45.24M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Flexion Therapeutics FLXN:US $ 3.73M 1.25M
Halozyme Therapeutics HALO:US $ 18.59M 4.43M
Insmed INSM:US $ 10.18M 654K
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Karyopharm Therapeutics KPTI:US $ 589K 549K
Kindred Biosciences KIN:US $ 639K 49K
MacroGenics MGNX:US 1.66M 1.64M
Mannkind MNKD:US $ 9.89M 0.04M
Merk MRK:US $ 3056M 14M
Novo Nordisk A Fs NVO:US $ 6059M 512M
Peregrine Pharmaceuticals PPHM:US $ 19.36M 0.1M
Pfizer PFE:US $ 9931M 2939M